Impression Healthcare launches Knight Guard
Published 22-JUN-2017 10:28 A.M.
|
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Distributor of dental health products, Impression Healthcare (ASX: IHL) has further expanded its product portfolio with the addition of night guards (The Knight Guard) to its product offerings.
IHL’s lead product Gameday mouthguards which have applications in the contact sport arena have been particularly well received, and with this new product also having the characteristics of a fitted mouthguard, the company’s entry into this new market should benefit from the expertise gained especially on the logistics side of the business.
Branded The Knight Guard, this product is aimed at addressing the problem of teeth grinding, which according to the Sleep Health Foundation affects 50% of the population on an occasional basis with 5% experiencing regular jaw clenching or Bruxism.
In keeping with the Gameday mouthguard products, IHL uses its patented self-impression system and technology to deliver high-quality teeth grinding protection direct to consumers. Importantly, this new product is included on the register of the Therapeutic Goods Administration (TGA).
IHL to benefit from experience in direct to consumer marketing and distribution
The direct to consumer model delivers considerable savings compared with the cost of purchasing similar products from dentists. The Knight Guard will be released in four product types ranging from approximately $130 to $230.
While management has a comprehensive marketing campaign planned for this new product, it has been buoyed by the level of early sales.
Looking across IHL’s product portfolio the company has made impressive progress in a short period of time, having achieved total combined sales of more than 5000 units across its Gameday, Instant Teeth Whitening (ITW) and The Knight Guard products.
Of course this is still an early stage play and investors should seek professional financial advice if considering this stock for their portfolio.
IHL’s Chief Executive, Matt Weston underlined the importance of Knight Guard and its contribution to the company’s product diversification strategy. However he also commented that IHL was focused on executing an aggressive growth strategy through acquisition and international expansion with a number of prospects currently in progress.
General Information Only
This material has been prepared by StocksDigital. StocksDigital is an authorised representative (CAR 000433913) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573).
This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
